Inflammatory Breast Cancer International Consortium
What is Inflammatory Breast Cancer (IBC)?
Inflammatory breast cancer is a rapidly progressing and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed.
Inflammatory breast cancer progresses rapidly, often in a matter of weeks or months. At diagnosis, inflammatory breast cancer is either stage III or IV disease, depending on whether cancer cells have spread only to nearby lymph nodes or to other tissues as well.
Learn more about IBC symptoms, diagnosis and treatment options. More >
About the Inflammatory Breast Cancer International Consortium (IBC-IC)
The Inflammatory Breast Cancer International Consortium (IBC-IC) was founded to foster collaboration among inflammatory breast cancer (IBC) researchers and clinicians.
The focus of our collaboration is to advance the leading research, education and information that will lead to the best outcomes and cures for IBC throughout the world. Our researchers and clinicians work at many of the leading cancer institutions worldwide.
Learn more about the IBC-IC’s mission, history and leadership. More >
IRB Survey
The purpose of this registry is to learn about the global characteristics of Inflammatory Breast Cancer and to be used as a launching pad for future research studies with interested participants. View our Survey Protocol & Consent Information.
Take the SurveyCOVID-19 Questionnaire
We are looking for feedback from physicians and patients regarding COVID-19.
Physicians’ COVID-19 Questionnaire Patients’ COVID-19 Questionnaire2021 Letter from IBC-IC President: Massimo Cristofanilli, MD, FACP
“As we begin to navigate through 2021, I believe we will no doubt remember 2020, and all of its many challenges. We have witnessed an unprecedented pandemic that has forever changed our lives. It has impacted our habits...”
Read the Full LetterClinicians & Researchers
Affiliated researchers, scientists and clinicians committed to advancing the science and medicine of IBC to improve screening, early detection, treatment options and patient outcomes.
Find an IBC clinician or researcher >
Centers
Leading cancer institutions focused on IBC advancing research, education and information that will lead to the best outcomes and cures for IBC throughout the world.
Find an IBC center >